Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans

Vaccine

Volumn 15, Issue 9, 1997, Pages 944-947

  Mao, J S ^a   Chai, S A ^a   Xie, R Y ^a   Chen, N L ^a   Jiang, Q ^b   Zhu, X Z ^b   Zhang, S Y ^a   Huang, H Y ^a   Mao, H W ^a   Bao, X N ^a   Liu, C J ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b Ctr for Sanitary and Prev of Dis   (China)

Author keywords

Hepatitis A; Safety efficacy; Vaccines; Virus

Indexed keywords

HEPATITIS A VACCINE; LIVE VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HEPATITIS A; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HEPATITIS ANTIBODIES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; SEROTYPING; VACCINES, ATTENUATED; VIRAL HEPATITIS VACCINES;

EID: 0031171172     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00304-0     Document Type: Article

References (4)

1. 1 Mao, J.S., Dong, D.X., Zhang, H.Y. et al. Study of attenuated live hepatitis A vaccine (H2 strain) in humans. J. Infect. Dis. 1989, 159, 621-624
2. 2 Mao, J.S., Xie, R.Y. and Huang, H.Y. et al. Studies in monkeys of attenuated hepatitis A variants. Scientia Sinica 1988, 31, 338-343
3. 3 Midthun, K., Ellerbeck, E. and Gershman, K. et al. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. J. Infect. Dis. 1991, 163, 735-739
4. 4 Melnick, J.L. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull. WHO 1978, 56, 21